Biotech

All Articles

Lykos will certainly ask FDA to rethink its own decision complying with being rejected of MDMA therapy for trauma

.Following a poor revealing for Lykos Therapeutics' MDMA applicant for post-traumatic stress disorde...

AN 2 one-halfs headcount, stops period 3 test after records disappoint

.AN2 Therapies is actually reviewing its business in reaction to dull midphase data, swearing to lay...

Merck spends $700M for bispecific, spying autoimmune opening and also odds to challenge Amgen in cancer cells

.Merck &amp Co. is paying out $700 thousand in advance to test Amgen in a blood cancer cells market....

Gilead pays out J&ampJ $320M to leave licensing offer for seladelpar

.Along With Gilead Sciences almost an FDA selection for its liver ailment medication seladelpar, the...

' All palms on deck' at Lilly as peers target weight problems market

.CEO David Ricks may see the business setting up outdoors tents at basecamp behind Eli Lilly in an e...

Entero giving up team, vacating workplace and pausing R&ampD

.Bed mattress Liquidators has actually turned Entero Therapeutics white colored as a piece. The cred...

Exelixis goes down ADC after choosing it is actually no match for Tivdak

.Exelixis is surrendering on its tissue factor (TF)- targeting antibody-drug conjugate after conclud...

Relay loses interest in SHP2 prevention after Genentech leaves

.3 weeks after Roche's Genentech system bowed out an SHP2 inhibitor treaty, Relay Therapy has actual...

Stoke's Dravet syndrome med launched of partial clinical grip

.Stoke Therapies' Dravet syndrome drug has actually been actually devoid of a predisposed hold, clea...

Fierce Biotech's Gabrielle Masson presents Strong 15 at NYSE

.Brutal Biotech Colleague Editor Gabrielle Masson showed the 2024 lesson of Tough 15 winners on the ...